Skip to content

Cumberland Pharmaceuticals Inc.: filings

Every Cumberland Pharmaceuticals Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-07fiscal Q2 2026461290001087294-26-000062
10-Q2026-05-08fiscal Q1 202544910001087294-26-000049
10-K2026-03-09fiscal FY 2025511430001087294-26-000020
10-Q2025-11-07fiscal Q3 2025451290001087294-25-000020
10-Q2025-08-08fiscal Q2 2025451260001628280-25-039326
10-Q2025-05-09fiscal Q1 202545930001628280-25-024342
10-K2025-03-07fiscal FY 2024511440001628280-25-011366
10-Q2024-11-08fiscal Q3 2024441280001628280-24-046730
10-Q2024-08-09fiscal Q2 2024441240001628280-24-036529
10-Q2024-05-10fiscal Q1 202444910001628280-24-022658
10-K2024-03-13fiscal FY 2023511440001628280-24-010725
10-Q2023-11-13fiscal Q3 2023411170001628280-23-038418
10-Q2023-08-11fiscal Q2 2023411130001628280-23-029112
10-Q2023-05-12fiscal Q1 202341850001628280-23-017951
10-K2023-03-13fiscal FY 2022531470001628280-23-007727
10-Q2022-11-14fiscal Q3 2022421230001628280-22-029906
10-Q2022-08-12fiscal Q2 2022421190001628280-22-022735
10-Q2022-05-13fiscal Q1 202242870001628280-22-014372
10-K2022-03-11fiscal FY 2021521750001628280-22-005942
10-Q2021-11-12fiscal Q3 2021421230001628280-21-023213
10-Q2021-08-13fiscal Q2 2021411150001628280-21-017022
10-Q2021-05-14fiscal Q1 202141850001628280-21-010387
10-K2021-03-12fiscal FY 2020511740001628280-21-004654
10-Q2020-11-13fiscal Q2 2020421210001628280-20-016446
10-Q2020-08-14fiscal Q2 2020421170001628280-20-012738
10-Q2020-05-22fiscal Q1 201943890001628280-20-008312
10-K2020-03-20fiscal FY 2019521760001628280-20-003880
10-Q2019-11-13fiscal Q3 2019431260001628280-19-014133
10-Q2019-08-14fiscal Q2 2019431220001628280-19-010781
10-Q2019-05-15fiscal Q1 201943900001628280-19-006841
10-K2019-03-12fiscal FY 2018491680001628280-19-002785
10-Q2018-11-14fiscal Q3 2018401100001628280-18-014380
10-Q2018-08-14fiscal Q2 2018391060001628280-18-011131
10-Q2018-05-09fiscal Q1 201839800001628280-18-006417
10-K2018-03-09fiscal FY 2017471550001628280-18-003034
10-Q2017-11-08fiscal Q3 2017391050001628280-17-011224
10-Q2017-08-09fiscal Q2 2017391050001628280-17-008470
10-Q2017-05-15fiscal Q1 201738780001628280-17-005580
10-K2017-03-13fiscal FY 2016461540001628280-17-002485
10-Q2016-11-03fiscal Q3 2016381040001628280-16-020795
10-Q2016-08-05fiscal Q2 2016381040001628280-16-018625
10-Q2016-05-13fiscal Q1 201638780001628280-16-016341
10-K2016-03-14fiscal FY 2015451510001628280-16-012682
10-Q2015-11-06fiscal Q3 2015381040001628280-15-008469
10-Q2015-08-07fiscal Q2 2015381040001628280-15-006327
10-Q2015-05-15fiscal Q1 201537760001628280-15-004273
10-K2015-03-09fiscal FY 2014451510001628280-15-001629
10-Q2014-11-07fiscal Q3 2014381040001445305-14-004964
10-Q2014-08-08fiscal Q2 2014381040001445305-14-003560
10-Q2014-05-12fiscal Q1 201438780001087294-14-000021
10-K2014-03-11fiscal FY 2013441480001087294-14-000010
10-Q2013-11-06fiscal Q3 2013381040001087294-13-000017
10-Q2013-08-09fiscal Q2 2013381040001087294-13-000009
10-Q2013-05-08fiscal Q1 201338780001445305-13-001190
10-K2013-03-12fiscal FY 2012431460001445305-13-000573
10-Q2012-11-02fiscal Q3 201236980001193125-12-449319
10-Q2012-08-09fiscal Q2 201236980001193125-12-347942
10-Q2012-05-04fiscal Q1 201235720001193125-12-212336
10-K2012-03-07fiscal FY 201137970001193125-12-101478
10-Q2011-11-07fiscal Q3 201136980000950123-11-096010
10-Q2011-08-08fiscal Q2 201136980000950123-11-074496

Inspect the source

Entity
Cumberland Pharmaceuticals Inc. / CIK 0001087294
Captured
2026-09-20T05:21:29.619Z
SEC response SHA-256
b37ed2fef35db1cde0c40b2233eb97cf370fc96d41a5c7d61b6a5a76a296e4a0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001087294.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))